Background: Multiple myeloma (MM) is a complex hematological malignancy with heterogeneous clinical and pathophysiological backgrounds that influence treatment responses and outcomes. Identifying biomarkers to predict drug response and guide treatment decisions, particularly regarding drug combinations, is essential to improve therapeutic efficacy and patient outcomes. This study explores the role of microRNAs ...
p. 2-7; Submitted by Suelen Reis (suziy.ellen@gmail.com) on 2014-03-20T13:12:27Z No. of bitstreams: 1 1746-6148-9-254.pdf: 694892 bytes, checksum: 2be9693d86424f2d32b669bf02848372 (MD5); Approved for entry into archive by Patricia Barroso (pbarroso@ufba.br) on 2014-03-21T20:44:30Z (GMT) No. of bitstreams: 1 1746-6148-9-254.pdf: 694892 bytes, checksum: 2be9693d86424f2d32b669bf02848372 (MD5); Made available in DS...
p. 1289-1296; Submitted by Edileide Reis (leyde-landy@hotmail.com) on 2014-04-29T13:14:56Z No. of bitstreams: 1 Byanca R. Araújo.pdf: 1030776 bytes, checksum: 21e0dec5f6dd68f24644228372743825 (MD5); Approved for entry into archive by Alda Lima da Silva (sivalda@ufba.br) on 2014-09-08T20:51:19Z (GMT) No. of bitstreams: 1 Byanca R. Araújo.pdf: 1030776 bytes, checksum: 21e0dec5f6dd68f24644228372743825 (MD5); Made ...